Oncology Drugs Market 2021 Research Report by Experts- Novartis AG, Johnson and Johnson, Pfizer Inc., AstraZeneca PLC, AbbVie Inc, Amgen, Eli Lilly

Global Oncology Drugs Market 2021 research report offers qualitative and quantitative insights in relation to industry growth rate, market segmentation, Oncology Drugs market size, demand and revenue. The current Oncology Drugs market trends that are expected to influence the future prospects of the industry are analyzed in the report. The report further investigates and assesses the current landscape of the ever-evolving business sector and the present and future effects of COVID-19 on the market.

The global oncology drugs market reached a value of nearly $160.45 billion in 2020, having increased at a compound annual growth rate (CAGR) of 6.8% since 2015. The market is expected to grow from $160.45 billion in 2020 to $243.81 billion in 2025 at a rate of 8.7%. The growth is mainly due to rise in incidence of various cancer conditions, increase in popularity of advance therapies (biological and targeted drug therapies), and surge in geriatric population worldwide. The market is expected to grow slightly from $160.45 billion in 2020 to $167.52 billion in 2021 at a CAGR of 4%. The market is expected to stabilize and reach $243.81 billion in 2025 and $358.45 billion in 2030.

Inquire for Sample Copy of this Report:

https://www.marketinsightsreports.com/reports/09223281877/oncology-drugs-global-market-opportunities-and-strategies-to-2030-covid-19-impact-and-recovery-including-1-by-type-lung-cancer-pancreatic-cancer-breast-cancer-prostate-cancer-ovarian-cancer-colorectal-cancer-gastric-cancer-kidney-cancer-brain-cancer-thyroid-cancer-skin-cancer-bladder-cancer-cervical-cancer-blood-cancer-others-2-by-drug-class-type-chemotherapy-targeted-therapy-immunotherapy-biologic-therapy-hormonal-therapy-3-by-distribution-channel-hospital-pharmacies-retail-pharmacies-drug-stores-others-4-by-route-of-administration-oral-parenteral-others-5-by-drug-classification-branded-drugs-generic-drugs-covering-bristol-myers-squibb-company-f-hoffmann-la-roche-ag-merck-co-inc-novartis-ag-johnson-johnson-pfizer-inc-astrazeneca-plc-abbvie-inc-amgen-eli-lilly/inquiry?Mode=S48  

Market Growth:

The global pharmaceutical drugs market, of which the oncology drugs market is a segment, reached a value of nearly $980.90 billion in 2020, growing at a compound annual growth rate (CAGR) of 4.9% since 2015. It is expected to grow at a CAGR of 7.4% and reach nearly $1,399.98 billion by 2025. The oncology drugs market was the largest segment in the global pharmaceutical drugs market accounting for 27.0% of the total in 2020. The ophthalmology drugs market was the smallest segment of the global pharmaceutical drugs market, accounting for 1.9% of the total and was valued at $18.18 billion in 2020.
The top opportunities in the oncology drugs market segmented by type will arise in the blood cancer segment, which will gain $16.2 billion of global annual sales by 2025. The top opportunities in the oncology drugs market segmented by drug class type will arise in the targeted therapy segment, which will gain $44.0 billion of global annual sales by 2025.The top opportunities in the oncology drugs market segmented by distribution channel will arise in the hospital pharmacies segment, which will gain $48.2 billion of global annual sales by 2025. The top opportunities in the oncology drugs market segmented by drug classification will arise in the branded drugs segment, which will gain $76.5 billion of global annual sales by 2025. The top opportunities in the oncology drugs market segmented by route of administration will arise in the oral segment, which will gain $48.7 billion of global annual sales by 2025. The oncology drugs market size will gain the most in the USA at $36.5 billion.

Scope of this Report:

Markets Covered: 1) By Type: Lung Cancer; Pancreatic Cancer; Breast Cancer; Prostate Cancer; Ovarian Cancer; Colorectal Cancer; Gastric Cancer; Kidney Cancer; Brain Cancer; Thyroid Cancer; Skin Cancer; Bladder Cancer; Cervical Cancer; Blood Cancer; Others
2) By Drug Class Type: Chemotherapy; Targeted Therapy; Immunotherapy (Biologic Therapy); Hormonal Therapy
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/Drug Stores; Others
4) By Route of Administration: Oral; Parenteral; Others
5) By Drug Classification: Branded Drugs; Generic Drugs
Companies Mentioned: Bristol-Myers Squibb Company; F. Hoffmann-La Roche AG; Merck & Co., Inc.; Novartis AG; Johnson & Johnson; Pfizer Inc.; AstraZeneca PLC; AbbVie Inc.; Amgen; Eli Lilly
Metrics Covered: Number of Enterprises; Number of Employees
Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, Oncology Drugs indicators comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Buy this Report:

https://www.marketinsightsreports.com/report/purchase/09223281877?mode=su?Mode=S48

Executive Summary:

The oncology drugs market is segmented by type into drugs for lung cancer, pancreatic cancer, breast cancer, prostate cancer, ovarian cancer, colorectal cancer, gastric cancer, kidney cancer, brain tumor, thyroid cancer, skin cancer, bladder cancer, cervical cancer, blood cancer and others. The blood cancer was the largest segment of the oncology drugs market by type, accounting for 19.4% of the total market in 2020. Going forward, ovarian cancer segment is expected to be the fastest growing segment in the oncology drugs market, at a CAGR of 19.9%.
The oncology drugs market is also segmented by drug class type into targeted therapy, immunotherapy (biologic therapy), chemotherapy and hormonal therapy. The targeted therapy was the largest segment of the oncology drugs market by drug class type, accounting for 43.1% of the total market in 2020. Going forward, the chemotherapy segment is expected to be the fastest growing segment in the oncology drugs market, at a CAGR of 13.3%.
The oncology drugs market is also segmented by distribution channel into hospital pharmacies, retail pharmacies/drug stores and others. The hospital pharmacies was the largest segment of the oncology drugs market by distribution channel, accounting for 51.2% of the total market in 2020. Going forward, the hospital pharmacies segment is expected to be the fastest growing segment in the oncology drugs market, at a CAGR of 9.7%. The oncology drugs market is also segmented by route of administration into oral, parental and others. The parental was the largest segment of the oncology drugs market by route of administration, accounting for 52.7% of the total market in 2020. Going forward, the others segment is expected to be the fastest growing segment in the oncology drugs market, at a CAGR of 12.7%.
The oncology drugs market is also segmented by drug classification into branded drugs and generic drugs. The branded drugs was the largest segment of the oncology drugs market by drug classification, accounting for 94.2% of the total market in 2020. Going forward, the generic drugs segment is expected to be the fastest growing segment in the oncology drugs market, at a CAGR of 11.6%.

Regional Analysis For Oncology Drugs Market:

North America (The United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

North America was the largest region in the global oncology drugs market, accounting for 41.2% of the total in 2020. It was followed by the Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the oncology drugs market will be South America and Middle East, where growth will be at CAGRs of 12.7% and 10.8% respectively. These will be followed by North America and Eastern Europe, where the markets are expected to register CAGRs of 9.6% and 8.1% respectively.

Browse the Report Description And TOC:

https://www.marketinsightsreports.com/reports/09223281877/oncology-drugs-global-market-opportunities-and-strategies-to-2030-covid-19-impact-and-recovery-including-1-by-type-lung-cancer-pancreatic-cancer-breast-cancer-prostate-cancer-ovarian-cancer-colorectal-cancer-gastric-cancer-kidney-cancer-brain-cancer-thyroid-cancer-skin-cancer-bladder-cancer-cervical-cancer-blood-cancer-others-2-by-drug-class-type-chemotherapy-targeted-therapy-immunotherapy-biologic-therapy-hormonal-therapy-3-by-distribution-channel-hospital-pharmacies-retail-pharmacies-drug-stores-others-4-by-route-of-administration-oral-parenteral-others-5-by-drug-classification-branded-drugs-generic-drugs-covering-bristol-myers-squibb-company-f-hoffmann-la-roche-ag-merck-co-inc-novartis-ag-johnson-johnson-pfizer-inc-astrazeneca-plc-abbvie-inc-amgen-eli-lilly?Mode=S48

Important Features that are under Offering and Key Highlights of the Reports:

– Detailed overview of Market

– Changing market dynamics of the industry

– In-depth market segmentation by Type, Application etc.

– Historical, current and projected market size in terms of volume and value

– Recent industry trends and developments

– Competitive landscape of Market

– Strategies of key players and product offerings

– Potential and niche segments/regions exhibiting promising growth

The research includes historic data from 2015 to 2021 and forecasts until 2030 which makes the report an invaluable resource for industry executives, marketing, sales, and product managers, consultants, analysts, and stakeholders looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Please connect with our sales team (sales@marketinsightsreports.com ).

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.